NIDA Avenir Award
Supports early-stage investigators building addiction science in HIV, substance use, genetics, and epigenetic research.
The NIDA Avenir Award uses the DP2 mechanism to foster innovation from investigators at the very beginning of their independent research careers. NIDA describes Avenir recipients as "the future of addiction science." The award is available in two distinct tracks: Track 1 covers HIV and substance use, and Track 2 covers genetics and epigenetics of addiction. Each track has its own scientific scope …
Innovative addiction science by early-stage investigators across two tracks: HIV and substance use, or genetics and epigenetics of addiction.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline